12,13-diHOME INJECTION = FAT EJECTION (Patreon)

Researchers are exploring a new compound that could improve metabolic health by improving insulin sensitivity, body composition, fat utilization, and glucose tolerance. This compound, which comes from cold exposure, is a key part of the puzzle in improving insulin sensitivity, body composition, fat utilization, and glucose tolerance. The compound, called 12,13-diHOME, is produced during exercise and has been linked to improved fatty acid utilization in the muscle. A study found that subjects exposed to sub-60°C for 90 minutes produced or released a lipocine called 12,13-diHOME, which increases fatty acid utilization in the muscle. This suggests that cold exposure and exercise may be linked, as previous research found that cold exposure twice a week improved insulin sensitivity. This suggests that cold exposure could be a modulator of inflammation, restoring insulin sensitivity in those metabolically damaged. The discovery could lead to the development of new products and treatments for metabolic health.